Morgan Stanley Finance LLC has introduced a new structured investment product offering exposure to U.S. equities through leveraged, buffered notes linked to the S&P 500 Index. The notes, priced at $1,000 per unit with an estimated trade-date value of approximately $985.40, provide investors with 150% participation in positive index performance while offering downside protection of up to 7.50%. The offering represents the firm's latest addition to its Series A Global Medium-Term Notes program and targets investors seeking enhanced equity market exposure with defined risk parameters.

Key Points

  • NYSE: MS-PQ
  • Morgan Stanley Finance LLC introduced Leveraged Buffered S&P 500 Index-Linked Notes due between 17 and 20 months from trade date
  • Notes offer 150% upside participation in positive S&P 500 performance, capped at a maximum settlement amount between $1,184.20 and $1,216.00 per $1,000 face value
  • Investors retain full principal protection if the S&P 500 declines by up to 7.50%, but face full loss of investment if index falls more than 7.50%

Structured Product Design and Index Linkage Architecture

Morgan Stanley Finance LLC has structured these notes to provide a combination of upside leverage and downside buffering, creating a payoff profile designed to appeal to investors seeking enhanced returns during rising equity markets while maintaining partial capital protection during moderate declines. The notes are unsecured obligations of MSFL, fully and unconditionally guaranteed by Morgan Stanley, meaning investors rely on the parent company's creditworthiness for repayment. The investment vehicle tracks the S&P 500 Index performance measured from the trade date through a determination date expected to occur between 17 and 20 months after issuance.

The pricing structure reflects both a debt component and a performance-based component tied to the underlying index. Morgan Stanley determined the economic terms, including the 150% upside participation rate and the cap level, using an internal funding rate described as likely lower than the firm's secondary market credit spreads. This funding rate differential affects the overall terms offered to investors, as the disclosure explains that higher internal funding rates or lower issuance costs would result in more favorable economic terms to note holders.

Leverage Mechanics and Return Calculation Framework

The notes employ a leveraged return structure that amplifies positive index movements while maintaining asymmetric downside protection. When the S&P 500 Index rises above its initial level on the determination date, investors receive $1,000 principal plus 150% of the index gain, multiplied by $1,000, subject to a maximum settlement cap. The filing states that this cap is expected to range between $1,184.20 and $1,216.00 for each $1,000 in face value, effectively capping the maximum gain at roughly 18.4% to 21.6% per $1,000 invested depending on final cap determination.

Return calculations employ a specific mathematical formula disclosed in the prospectus supplement. If the index return is positive, the calculation multiplies $1,000 by the 150% leverage factor by the underlier return, then adds the $1,000 principal, subject to the cap. This three-component structure—principal recovery, leverage application, and upside cap—defines the entire payoff function for positive market scenarios, creating a defined maximum benefit that protects the issuer from unlimited liability.

Downside Buffer Mechanism and Capital Loss Thresholds

The notes provide what Morgan Stanley describes as a "buffer" against moderate index declines, protecting investors' full principal if the S&P 500 falls by no more than 7.50% from the initial level. This means investors receive their full $1,000 investment back even if the index declines substantially, as long as the loss does not exceed 7.50% from the starting point. This protection mechanism is designed to offer investors confidence that typical market corrections may not impair their capital, provided the decline remains within the buffered zone.

However, if the index declines by more than 7.50%, investors face proportional losses calculated using the formula disclosed in the pricing supplement: approximately 1.0811 times the sum of the underlier return plus 7.50%, multiplied by $1,000. This structure means a steeper loss beyond the buffer threshold, and the disclosure explicitly warns that investors could lose their entire investment if the index falls sufficiently. The filing emphasizes multiple times that principal is at risk and that total capital loss is possible, positioning this as a principal-at-risk security despite the buffer feature.

Issuance Economics and Estimated Trade-Date Valuation

The notes are issued at $1,000 per unit, with Morgan Stanley & Co. charging an agent's commission of $11.20 per note, or 1.12% of the face value. The firm estimates that the trade-date value of each note will be approximately $985.40, representing a discount of approximately $14.60 per $1,000 face value. This discount reflects all costs associated with issuing, selling, structuring, and hedging the notes, which are borne by investors at the outset and reduce the effective starting value of the investment below par.

The disclosure explains that this estimated value incorporates Morgan Stanley's own pricing and valuation models, market inputs, volatility assumptions, interest rate expectations, and the firm's secondary market credit spread. The estimated value is determined as of the trade date and may vary from actual secondary market prices due to bid-offer spreads and other factors. Notably, the filing discloses that for up to three months following issuance, absent changes in market conditions or credit spreads, secondary market values may be higher than the estimated trade-date value, since some issuance costs are amortized over time rather than deducted immediately.

Credit Risk and Guarantee Structure

The notes carry direct credit risk tied to Morgan Stanley Finance LLC and are backed by Morgan Stanley's full and unconditional guarantee. The disclosure states explicitly that "all payments are subject to our credit risk" and that if Morgan Stanley defaults on its obligations, investors could lose some or all of their investment. The notes are unsecured obligations, meaning they are not backed by any specific assets or collateral, and investors have no security interest in or access to any underlying reference asset. This structure creates a direct counterparty risk that investors must evaluate alongside the market risk of the S&P 500 Index.

The guarantee structure does not change this fundamental credit exposure—it merely commits the parent company (Morgan Stanley) to honor the subsidiary's (MSFL) obligations. Investors should note that the notes are not deposits, savings accounts, or FDIC-insured products, nor are they obligations of or guaranteed by any bank other than Morgan Stanley entities. This distinction is material for investors accustomed to bank deposit protections or government-backed securities.

Secondary Market Liquidity and Dealer Distribution

Morgan Stanley & Co. will purchase all notes issued by MSFL and resell them to an unaffiliated dealer network, which receives a fixed sales commission of 1.12% for each note sold. This distribution structure means MS & Co. acts as the sole initial purchaser from the issuer before the notes flow to retail or institutional investors through dealer intermediaries. The arrangement does not obligate MS & Co. to maintain a secondary market—the disclosure explicitly states that MS & Co. "may, but is not obligated to, make a market in the notes, and, if it once chooses to make a market, may cease doing so at any time."

The absence of mandatory secondary market making represents a liquidity risk for note holders seeking to exit positions before maturity. While MS & Co. may purchase notes in the secondary market at prices potentially higher than the estimated trade-date value during the first three months post-issuance, this is discretionary. Secondary market prices, when available, will reflect bid-offer spreads charged by MS & Co. and changes in market conditions, S&P 500 volatility, and Morgan Stanley's credit spreads, potentially resulting in prices below the original purchase price depending on market movements and timing.

Tax Treatment and Regulatory Status

The preliminary pricing supplement references accompanying tax supplement documentation dated April 8, 2026, which addresses the federal income tax treatment of the notes but is not included in the filing excerpts provided. Investors should review the tax supplement in conjunction with this disclosure to understand the specific tax implications of owning and receiving payments on these notes. The tax treatment may vary depending on individual investor circumstances and applicable tax law, and investors are advised to consult tax professionals regarding their specific situations.

The notes are registered under Securities and Exchange Commission registration statements numbered 333-293641 and 333-293641-01, and this preliminary pricing supplement is filed as a 424(b)(2) document. The SEC has not approved or disapproved the notes or the accompanying documentation, a standard disclaimer that underscores the SEC's role as a regulator focused on disclosure adequacy rather than investment merit. State securities regulators have similarly not approved the offering, emphasizing that this represents a preliminary pricing supplement subject to completion and final terms approval.

Risk Factors and Investor Considerations

The notes involve multiple layers of risk beyond those associated with conventional debt securities. Market risk on the S&P 500 Index is the primary risk—if the index declines more than 7.50%, investors face losses proportional to the decline magnitude, with total capital loss possible. Credit risk tied to Morgan Stanley represents a second significant risk dimension: if the firm defaults, note holders have no priority claim on specific assets and are unsecured creditors. Liquidity risk affects the ability to exit before maturity, as secondary market purchases by MS & Co. are discretionary and subject to bid-offer spreads and changed market conditions.

The filing emphasizes that investors should read the "Risk Factors" section beginning on page 10 of the accompanying prospectus and product supplement for comprehensive discussion of risks. Additional risks may include leverage risk (the 150% participation amplifies losses when the index exceeds the cap), reinvestment risk, interest rate risk affecting valuation, and volatility risk, which affects both the valuation model's assumptions and the secondary market price. The disclosure repeatedly warns that investors could lose their entire investment, a statement that must be weighed carefully against the buffer feature when considering risk-return tradeoffs.

Maturity Timeline and Final Pricing Mechanics

The notes are expected to mature between 17 and 20 months after the trade date, with the stated maturity occurring on the second scheduled business day after the determination date. On this maturity date, investors receive a single cash payment calculated according to the formulas disclosed in the pricing supplement based on the final S&P 500 Index level compared to the initial level established on the trade date. The exact maturity date will be specified in the final pricing supplement once pricing is completed, as this preliminary document notes that the information provided is not complete and may be changed.

The initial underlier level, which serves as the reference point for all return calculations, is set on the trade date and may be higher or lower than the actual closing level of the S&P 500 Index on that date. This distinction is important because it means the reference level used for calculating returns is determined by Morgan Stanley's pricing process rather than simply the published index close. The determination date—the date on which the final underlier level is measured for payment calculation—is also expected to be set between 17 and 20 months after trade, with the final determination dates specified in the final pricing supplement.

Use of Proceeds and Hedging Activities

Morgan Stanley discloses that proceeds from the note sale will be used for purposes detailed in the "Use of proceeds and hedging" section beginning on page 18 of the accompanying prospectus supplement. The filing indicates that Morgan Stanley will conduct hedging activities related to these notes but does not provide specific details about hedging strategy, counterparties, or costs in the preliminary pricing supplement excerpts provided. Hedging costs and activities may affect the firm's pricing of the notes and the internal funding rate used to determine economic terms.

The disclosure notes that if issuing, selling, structuring, and hedging costs were lower or if the internal funding rate were higher, economic terms would be more favorable to investors. This statement acknowledges that the cost structure embedded in the notes reflects Morgan Stanley's hedging expenses and internal cost allocation methodology. Investors should understand that a portion of the initial discount from par ($14.60 per $1,000) reflects these hedging and operational costs, though the filing does not itemize costs separately.